Coloplast A/S - FY 2023/24 Earnings Release - Invitation for conference call on 5 November 2024 at 11.00 CET

GlobeNewswire
2024-10-21

Tuesday, 5 November 2024 at 11.00 – 12.00 CET
In connection with the publication of Coloplast's interim financial results for FY 2023/24 the company will host a conference call to present the financial results and answer questions from investors and financial analysts.
A presentation will be available on Coloplast's website approximately 1 hour before the conference call.
Please note that the webcast of the conference call will be available during and after the event.





Coloplast will be represented by:
Kristian Villumsen - President & CEO
Anders Lonning-Skovgaard - Executive Vice President, CFO
Aleksandra Dimovska - Vice President, Investor Relations
Kristine Husted Munk - Senior Manager, Investor Relations 




Webcast

Any participants who do not wish to actively participate in the question & answer session, please access the conference call as a webcast directly by clicking here:

Access the webcast here


Dial-in details
For analysts and any participants wishing to actively participate in the question & answer session please sign up ahead of the conference call on the link below to receive an email with dial-in details: 

Register here

For more information, please contact:

Aleksandra Dimovska, Vice President, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2458, e-mail: dkadim@coloplast.com

Kristine Husted Munk, Senior Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3266, e-mail: dkkhu@coloplast.com

Julie Sommer Müggler, Coordinator & PA, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 3161, e-mail: dkjusm@coloplast.com

Konstancija Norvilaite, Associate IR & Finance Manager, Investor Relations
Tel.: +45 4911 1800 / direct: +45 4911 2803, e-mail: dkkono@coloplast.com

Coloplast will be available on individual phone lines after the conference call for further questions.

Attachment

  • Invitation for Coloplasts FY 2023-24 conference call on 5 November 2024

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10